Mirum Pharmaceuticals (NASDAQ:MIRM) Given “Buy” Rating at HC Wainwright
HC Wainwright reaffirmed their buy rating on shares of Mirum Pharmaceuticals (NASDAQ:MIRM – Free Report) in a research report released on Friday, Benzinga reports. They currently have a $66.00 price target on the stock. A number of other equities analysts have also commented on MIRM. JPMorgan Chase & Co. raised their target price on shares […]
More Stories
Analysts Set Healthpeak Properties, Inc. (NYSE:DOC) Target Price at $22.17
Healthpeak Properties, Inc. (NYSE:DOC – Get Free Report) has been assigned an average rating of “Moderate Buy” from the fourteen...
Hilton Worldwide Holdings Inc. (NYSE:HLT) Shares Bought by Wedmont Private Capital
Wedmont Private Capital boosted its stake in shares of Hilton Worldwide Holdings Inc. (NYSE:HLT – Free Report) by 3.1% in...
Sanibel Captiva Trust Company Inc. Lowers Position in Ford Motor (NYSE:F)
Sanibel Captiva Trust Company Inc. lessened its position in shares of Ford Motor (NYSE:F – Free Report) by 3.4% in...
8,778 Shares in Sprouts Farmers Market, Inc. (NASDAQ:SFM) Bought by Private Advisory Group LLC
Private Advisory Group LLC bought a new stake in Sprouts Farmers Market, Inc. (NASDAQ:SFM – Free Report) during the third...
Private Advisory Group LLC Has $996,000 Position in Invesco Dorsey Wright Momentum ETF (NASDAQ:PDP)
Private Advisory Group LLC boosted its stake in shares of Invesco Dorsey Wright Momentum ETF (NASDAQ:PDP – Free Report) by...
Private Advisory Group LLC Reduces Holdings in SAP SE (NYSE:SAP)
Private Advisory Group LLC lessened its position in shares of SAP SE (NYSE:SAP – Free Report) by 92.2% during the...